Literature DB >> 31169893

Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles.

Tae-Wook Chun1, Robert W Eisinger2, Anthony S Fauci2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31169893     DOI: 10.1001/jama.2019.5397

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Toward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are Developed.

Authors:  Jeffrey M Jacobson; Kamel Khalili
Journal:  AIDS Rev       Date:  2018       Impact factor: 2.500

2.  Combination anti-HIV antibodies provide sustained virological suppression.

Authors:  Michael C Sneller; Jana Blazkova; Susan Moir; Tae-Wook Chun; J Shawn Justement; Victoria Shi; Brooke D Kennedy; Kathleen Gittens; Jekaterina Tolstenko; Genevieve McCormack; Emily J Whitehead; Rachel F Schneck; Michael A Proschan; Erika Benko; Colin Kovacs; Cihan Oguz; Michael S Seaman; Marina Caskey; Michel C Nussenzweig; Anthony S Fauci
Journal:  Nature       Date:  2022-06-01       Impact factor: 69.504

3.  Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement.

Authors:  Qingbo Liu; Peng Zhang; Huiyi Miao; Yin Lin; Young Do Kwon; Peter D Kwong; Zahra Rikhtegaran-Tehrani; Michael S Seaman; Anthony L DeVico; Mohammad M Sajadi; Paolo Lusso
Journal:  J Virol       Date:  2021-05-24       Impact factor: 5.103

4.  Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: a discrete choice experiment.

Authors:  Christel Protiere; Michael Arnold; Marion Fiorentino; Lisa Fressard; Jean D Lelièvre; Mohamed Mimi; François Raffi; Marion Mora; Laurence Meyer; Luis Sagaon-Teyssier; David Zucman; Marie Préau; Olivier Lambotte; Bruno Spire; Marie Suzan-Monti
Journal:  J Int AIDS Soc       Date:  2020-02       Impact factor: 5.396

5.  Combination anti-HIV antibodies to achieve antiretroviral therapy-free virological suppression in infected individuals.

Authors:  M Ali Rai; Tae-Wook Chun
Journal:  Clin Transl Med       Date:  2022-09

6.  Time to Engage Young People in HIV Cure Research.

Authors:  Parya Saberi; Chadwick K Campbell; Manuel Venegas; Karine Dubé
Journal:  AIDS Res Hum Retroviruses       Date:  2021-04-01       Impact factor: 2.205

7.  Potential of recombinant Mycobacterium paragordonae expressing HIV-1 Gag as a prime vaccine for HIV-1 infection.

Authors:  Byoung-Jun Kim; Bo-Ram Kim; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.